Similar Articles
Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric study
Jucier Gonçalves Júnior, Naoki Mugii, Pleiades Tiharu Inaoka, Renata Miossi, Fernando Henrique Carlos De Souza, João Calvino Soares De Oliveira, Fujiko Someya, Yasuhito Hamaguchi, Takashi Matsushita, Percival Degrava Sampaio-Barros, Samuel Katsuyuki Shinjo
DOI: 10.46497/ArchRheumatol.2023.9597
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydin, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Kucuksahin, Şükran Erten
DOI: 10.46497/ArchRheumatol.2023.10183
Males and females with scleroderma: A comparative study in a Brazilian sample
Matheus Costa, Igor Jorge, Patricia Martin, Renato Nisihara, Thelma Skare
DOI: 10.46497/ArchRheumatol.2023.10011
The evaluation of tibial nerve using shear-wave elastography and ultrasound in patients with systemic sclerosis: A cross-sectional study
Serdar Kaymaz, Murat Yiğit, Furkan Ufuk, Burak Sarılar, Uğur Karasu, Veli Çobankara, Nuran Sabir, Hakan Alkan
DOI: 10.46497/ArchRheumatol.2023.9835
Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study
Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger
DOI: 10.46497/ArchRheumatol.2024.10105
Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study
Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai
DOI: 10.46497/ArchRheumatol.2024.10418
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2024.10199
Lung involvement in patients with psoriatic arthritis
Mehmet Hünür, Tahir Saygın Öğüt, Ece Çelik, Funda Erbasan, Melis Dilbil, Mine Nokay, Mustafa Ender Terzioğlu, Veli Yazisiz
DOI: 10.46497/ArchRheumatol.2024.10537
Association of Health-Related Quality of Life with Functional and Radiological Outcomes in Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease, Systemic Sclerosis–Associated Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis
Irem Sahinoğlu, Deniz Kizilirmak, Sadettin Uslu, Mevlüt Kacar, Filiz Cemre Tasgöz, Seref Sülükcü, Emre Ali Acar, Müge Gencer Tuluy, Secil Sari, Ozgül Soysal Gündüz, Timur Pirildar
DOI: 10.5152/ArchRheumatol.2025.11105
Correlation of Pleural and Pulmonary Ultrasound with the Severity of Autoimmune Interstitial Lung Disease
Luis Javier Cajas Santana, Satiago Cuero, Gabriela Guerrero, Mayelin Ceballos, María Carolina Torres Villarreal
DOI: 10.5152/ArchRheumatol.2025.10999
Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang
DOI: 10.5152/ArchRheumatol.2025.25013